ES2097083A1 - Procedimiento para la preparcion de particulas tratadas en seco, las particulas tratadas en seco asi obtenidas, y composiciones farmaceuticas que contienen tales particulas. - Google Patents

Procedimiento para la preparcion de particulas tratadas en seco, las particulas tratadas en seco asi obtenidas, y composiciones farmaceuticas que contienen tales particulas.

Info

Publication number
ES2097083A1
ES2097083A1 ES09400996A ES9400996A ES2097083A1 ES 2097083 A1 ES2097083 A1 ES 2097083A1 ES 09400996 A ES09400996 A ES 09400996A ES 9400996 A ES9400996 A ES 9400996A ES 2097083 A1 ES2097083 A1 ES 2097083A1
Authority
ES
Spain
Prior art keywords
microballs
active ingredient
polymer
production
pharmaceutically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09400996A
Other languages
English (en)
Other versions
ES2097083B1 (es
Inventor
Jean Marc Ruiz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Publication of ES2097083A1 publication Critical patent/ES2097083A1/es
Application granted granted Critical
Publication of ES2097083B1 publication Critical patent/ES2097083B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE PARTICULAS TRATADAS EN SECO, LAS PARTICULAS TRATADAS EN SECO ASI OBTENIDAS, Y COMPOSICIONES FARMACEUTICAS QUE CONTIENEN TALES PARTICULAS, QUE TIENEN FORMA SUSTANCIALMENTE ESFEROIDAL Y CONSTAN DE UN INGREDIENTE ACTIVO INCORPORADO EN UN POLIMERO BIOCOMPATIBLE DE ALTO PUNTO DE FUSION, CUYO PROCEDIMIENTO COMPRENDE MEZCLAR, CON AGITACION, DICHO POLIMERO BIOCOMPATIBLE Y DICHO INGREDIENTE ACTIVO, DENTRO DE UNA FASE VISCOSA HOMOGENEA SUSTENTADORA, NO MISCIBLE, SIENDO DICHO INGREDIENTE ACTIVO Y DICHO POLIMERO BIOCOMPATIBLE INSOLUBLES EN DICHA FASE LIQUIDA HOMOGENEA SUSTENTADORA, LUEGO MANTENER LA AGITACION, HASTA LA FORMACION DE MICROBOLAS DEL POLIMERO BIOCOMPATIBLE Y LA INCORPORACION COMPLETA DEL INGREDIENTE ACTIVO EN LAS MISMAS, ESTANDO LA TEMPERATURA DE TRATAMIENTO POR ENCIMA DE LA TEMPERATURA DE TRANSICION VITREA DEL POLIMERO BIOCOMPATIBLE; Y FINALMENTE RECUPERAR LAS MICROBOLAS ASI OBTENIDAS.
ES09400996A 1993-05-15 1994-05-11 Procedimiento para la preparcion de particulas tratadas en seco, las particulas tratadas en seco asi obtenidas, y composiciones farmaceuticas que contienen tales particulas. Expired - Fee Related ES2097083B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939310030A GB9310030D0 (en) 1993-05-15 1993-05-15 Dry processed particles and process for the preparation of the same

Publications (2)

Publication Number Publication Date
ES2097083A1 true ES2097083A1 (es) 1997-03-16
ES2097083B1 ES2097083B1 (es) 1997-12-01

Family

ID=10735537

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09400996A Expired - Fee Related ES2097083B1 (es) 1993-05-15 1994-05-11 Procedimiento para la preparcion de particulas tratadas en seco, las particulas tratadas en seco asi obtenidas, y composiciones farmaceuticas que contienen tales particulas.

Country Status (35)

Country Link
JP (1) JP3139913B2 (es)
KR (1) KR100341261B1 (es)
CN (1) CN1050534C (es)
AT (1) AT406017B (es)
AU (1) AU685094B2 (es)
BE (1) BE1008323A3 (es)
BR (1) BR9401968A (es)
CA (1) CA2123481C (es)
CH (1) CH688572A5 (es)
DE (1) DE4416812C2 (es)
DK (1) DK171454B1 (es)
DZ (1) DZ1779A1 (es)
ES (1) ES2097083B1 (es)
FI (1) FI112915B (es)
FR (1) FR2705232B1 (es)
GB (2) GB9310030D0 (es)
GR (1) GR1002034B (es)
HK (1) HK1002831A1 (es)
HU (1) HU220617B1 (es)
IE (1) IE940392A1 (es)
IN (1) IN182330B (es)
IT (1) IT1269508B (es)
LU (1) LU88482A1 (es)
MA (1) MA23194A1 (es)
NL (1) NL9400795A (es)
NO (1) NO307403B1 (es)
NZ (1) NZ260520A (es)
OA (1) OA09939A (es)
PL (1) PL175780B1 (es)
PT (1) PT101518B (es)
RU (1) RU2125869C1 (es)
SE (1) SE519004C2 (es)
SG (1) SG46631A1 (es)
TN (1) TNSN94046A1 (es)
ZA (1) ZA943316B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK74495A3 (en) * 1993-01-06 1997-01-08 Kinerton Ltd Ionic molecular conjugates of biodegradable polyesters with bioactive polypeptides and a method of preparation thereof
ATE381349T1 (de) * 1993-01-06 2008-01-15 Ipsen Mfg Ireland Ltd Bioabbaubare polyester zur herstellung ionischer molekularer konjugate mit bioaktiven polypeptiden
DE19604744A1 (de) 1996-02-09 1997-08-14 Henkel Kgaa Technische Di-/Triglyceridgemische
IE960308A1 (en) 1996-04-23 1997-11-05 Kinerton Ltd Sustained release ionic conjugate
DE19617137C1 (de) * 1996-04-29 1997-02-27 Henkel Kgaa Verwendung von Copolymerestern für die Herstellung von Mikrosphären
US5858531A (en) * 1996-10-24 1999-01-12 Bio Syntech Method for preparation of polymer microparticles free of organic solvent traces
US6867181B1 (en) 1997-06-02 2005-03-15 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
AU1375301A (en) 1999-11-15 2001-05-30 Bio Syntech Canada Inc Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution
US6646083B2 (en) 2000-06-16 2003-11-11 Nippon Shokubai Co., Ltd. Crosslinked polymers containing tertiary amine and/or quaternary ammonium salt structures, processes for making and uses thereof
GB0705159D0 (en) * 2007-03-19 2007-04-25 Prosonix Ltd Process for making crystals

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2070153A1 (es) * 1969-10-23 1971-09-10 Du Pont
GB2246514A (en) * 1990-08-01 1992-02-05 Scras Sustained release particles preparation
WO1992021326A1 (en) * 1991-05-27 1992-12-10 Medinvent Method of producing reproducible particles

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
CH672887A5 (es) * 1987-10-14 1990-01-15 Debiopharm Sa
AU2810189A (en) * 1987-10-30 1989-05-23 Stolle Research & Development Corporation Low residual solvent microspheres and microencapsulation process
DE3916020C2 (de) * 1989-05-17 1994-06-01 Burkhard Dr Wichert Retardierende Mikropartikel aus bioabbaubaren Polyestern; Verfahren zu deren Herstellung unter Verzicht auf toxische Lösungsmittel und diese Mikropartikel enthaltende pharmazentische Zubereitungen
KR0168849B1 (ko) * 1990-04-12 1999-01-15 요시또시 가즈오 피목 조성물 및 그의 제조방법
JP3116311B2 (ja) * 1990-06-13 2000-12-11 エーザイ株式会社 マイクロスフィアの製法
GB9016885D0 (en) * 1990-08-01 1990-09-12 Scras Sustained release pharmaceutical compositions
SE9003296L (sv) * 1990-10-16 1992-04-17 Kabi Pharmacia Ab Foerfarande foer att formulera laekemedel
CA2055522A1 (en) * 1990-12-12 1992-06-13 Masako Andoh Microspheres for ophthalmic use
GB9203689D0 (en) * 1992-02-20 1992-04-08 Euro Celtique Sa Pharmaceutical composition
EP0630234B1 (en) * 1992-03-12 1997-06-11 Alkermes Controlled Therapeutics, Inc. Controlled release acth containing microspheres
SE9200858L (sv) * 1992-03-20 1993-09-21 Kabi Pharmacia Ab Metod för framställning av pellets med fördröjd frisättning
WO1993025221A1 (en) * 1992-06-11 1993-12-23 Alkermes Controlled Therapeutics, Inc. Erythropoietin drug delivery system
US5350584A (en) * 1992-06-26 1994-09-27 Merck & Co., Inc. Spheronization process using charged resins
JP2651320B2 (ja) * 1992-07-16 1997-09-10 田辺製薬株式会社 徐放性マイクロスフェア製剤の製造方法
FR2693905B1 (fr) * 1992-07-27 1994-09-02 Rhone Merieux Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues.
GB2273874A (en) * 1992-12-31 1994-07-06 Pertti Olavi Toermaelae Preparation of pharmaceuticals in a polymer matrix

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2070153A1 (es) * 1969-10-23 1971-09-10 Du Pont
GB2246514A (en) * 1990-08-01 1992-02-05 Scras Sustained release particles preparation
WO1992021326A1 (en) * 1991-05-27 1992-12-10 Medinvent Method of producing reproducible particles

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MATHIOWITZ E., Polyanhydride Microspheres as drug carners I. Hot-melt microencapsulation. Journal of Controlled Release 5 (1987) 13-22 *

Also Published As

Publication number Publication date
GB2277915B (en) 1997-10-29
GB9310030D0 (en) 1993-06-30
HK1002831A1 (en) 1998-09-18
BE1008323A3 (fr) 1996-04-02
RU2125869C1 (ru) 1999-02-10
IN182330B (es) 1999-03-20
FI942222A (fi) 1994-11-16
JPH072652A (ja) 1995-01-06
FR2705232B1 (fr) 1995-08-25
SE9401557L (sv) 1994-11-16
HU9401412D0 (en) 1994-08-29
ITMI940931A1 (it) 1995-11-11
TNSN94046A1 (fr) 1995-04-25
IE940392A1 (en) 1994-11-16
ZA943316B (en) 1995-01-16
ATA98794A (de) 1999-06-15
OA09939A (fr) 1994-11-15
ITMI940931A0 (it) 1994-05-11
GR1002034B (en) 1995-10-31
GB9409565D0 (en) 1994-07-06
DE4416812C2 (de) 2003-02-06
DK54994A (da) 1994-11-16
AT406017B (de) 2000-01-25
FR2705232A1 (fr) 1994-11-25
IT1269508B (it) 1997-04-01
CH688572A5 (fr) 1997-11-28
DZ1779A1 (fr) 2002-02-17
FI942222A0 (fi) 1994-05-13
NO307403B1 (no) 2000-04-03
HU220617B1 (hu) 2002-03-28
DE4416812A1 (de) 1994-11-17
PT101518A (pt) 1995-03-01
ES2097083B1 (es) 1997-12-01
NL9400795A (nl) 1994-12-01
PL175780B1 (pl) 1999-02-26
NO941810L (no) 1994-11-16
SE519004C2 (sv) 2002-12-17
NZ260520A (en) 1994-12-22
HUT67599A (en) 1995-04-28
BR9401968A (pt) 1994-12-13
NO941810D0 (no) 1994-05-13
CN1104557A (zh) 1995-07-05
PT101518B (pt) 2000-12-29
AU6308494A (en) 1994-11-17
DK171454B1 (da) 1996-11-04
GB2277915A (en) 1994-11-16
AU685094B2 (en) 1998-01-15
FI112915B (fi) 2004-02-13
KR100341261B1 (ko) 2002-09-27
CN1050534C (zh) 2000-03-22
CA2123481A1 (en) 1994-11-16
LU88482A1 (fr) 1994-12-01
SE9401557D0 (sv) 1994-05-05
CA2123481C (en) 2005-01-11
MA23194A1 (fr) 1994-12-31
SG46631A1 (en) 1998-02-20
JP3139913B2 (ja) 2001-03-05

Similar Documents

Publication Publication Date Title
ES2097083A1 (es) Procedimiento para la preparcion de particulas tratadas en seco, las particulas tratadas en seco asi obtenidas, y composiciones farmaceuticas que contienen tales particulas.
CA2030459A1 (en) Biodegradable ocular implants
HUP0001256A2 (hu) Biológiailag lebomló tereftalát-poliészter-polifoszfonát-polimerek, készítmények, eljárás előállításukra és alkalmazásuk
CA2358062A1 (en) Controlled release galantamine composition
CA2304568A1 (en) Olanzapine pamoate formulations
CA2101245A1 (en) Dosage forms comprising polymers comprising different molecular weights
CA2011171A1 (en) Biodegradable Poly (Phosphate Esters)
JO1613B1 (en) Derivatives of n - (3-hydroxy-4-piperidnil) dihydrobenzofuran, dihydro-2u-benzopyran or dihydro-benzodoxine) carboxymide
CA2270861A1 (en) Acetabular cup assembly with selected bearing
ID28432A (id) Senyawa-senyawa baru
NO890075L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazoler.
CA2432904A1 (en) Induced phase transition method for the production of microparticles containing hydrophobic active agents
EP0269745A4 (en) BONE IMPLANT.
AU1575888A (en) Joint prosthesis
FR2715306B1 (fr) Composition cosmétique ou dermopharmaceutique sous forme de pâte souple et procédé de préparation de ladite composition.
CA2105887A1 (en) Bioerodible device for administering active ingredients
EP0349100A3 (en) Macrolide compositions for treating gastro-intestinal motility disorders
CA2000763A1 (en) Dispersable formulation
EP0358150A3 (en) Use of 5-(4-chlorophenyl)-2,4-dimethyl-3h-1,2,4-triazole-3-thione for preparing drugs for the treatment of thrombocytosis
CA2335015A1 (en) Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug
NO950595L (no) Oftalmologisk preparat
MY119307A (en) Process for the preparation of microballs and microballs thus obtained
WO2001032230A3 (en) A polymer micelle as monolayer or layer-laminated surface
HUT56557A (en) Process for producing oxetanone derivatives and pharmaceutical compositions comprising same as active ingredient
FR2651230B1 (fr) Derives de la 5-amino-1,2,3,4 tetrahydro-acridine et applications comme medicaments.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19970316

Kind code of ref document: A1

Effective date: 19970316

FD2A Announcement of lapse in spain

Effective date: 20180806